Every open market buy and sale of Globus Medical Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $16M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when GMED insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an GMED officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every GMED insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | James R TobinDirector | Sale | 41,666 | $75.16 | $3.1M | 0 | Nov 12Form 4 |
| Nov 4, 2026 | Ann D RhoadsDirector | Sale plan | 5,000 | $85.00 | $425K | 35,384 | Nov 5Form 4 |
| Sep 15, 2026 | James R TobinDirector | Sale | 30,000 | $74.58 | $2.2M | 0 | Sep 16Form 4 |
| Aug 18, 2026 | Stephen T ZarrilliDirector | Sale | 25,000 | $87.04 | $2.2M | 0 | Aug 19Form 4 |
| Jun 5, 2026 | David D DavidarDirector | Sale | 25,000 | $80.76 | $2M | 510,175 | Jun 9Form 4 |
| Feb 25, 2026 | Kelly HullerEVP, GC, Corporate Secretary | Sale plan | 20,000 | $94.50 | $1.9M | 0 | Feb 27Form 4 |
| Feb 12, 2026 | Kelly HullerEVP, GC, Corporate Secretary | Sale plan | 10,000 | $87.67 | $877K | 0 | Feb 17Form 4 |
| Jan 8, 2026 | Leslie V NorwalkDirector | Sale plan | 2,000 | $101.10 | $202K | 10,419 | Jan 12Form 4 |
| Jan 8, 2026 | Kyle KlineSenior Vice President, CFO | Sale plan | 3,594 | $101.10 | $363K | 0 | Jan 12Form 4 |
| Dec 12, 2025 | Leslie V NorwalkDirector | Sale plan | 4,000 | $88.85 | $355K | 12,419 | Dec 16Form 4 |
| Dec 1, 2025 | Kyle KlineSenior Vice President, CFO | Sale plan | 18,542 | $90.00 | $1.7M | 0 | Dec 3Form 4 |
| Nov 25, 2025 | Kelly HullerSVP, GC, Corporate Secretary | Sale plan | 7,500 | $90.00 | $675K | 0 | Nov 28Form 4 |
| Nov 12, 2025 | David D DavidarDirector | Sale | 25,000 | $86.00 | $2.1M | 516,275 | Nov 13Form 4 |
| Nov 11, 2025 | Stephen T ZarrilliDirector | Sale | 25,000 | $84.29 | $2.1M | 0 | Nov 13Form 4 |
| Nov 10, 2025 | Ann D RhoadsDirector | Sale plan | 10,000 | $81.80 | $818K | 15,384 | Nov 10Form 4 |
GMED insider trading FAQ
Are GMED insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of GMED on the open market in 0 trades, and 7 sold $16M in 12 trades, 40% of that under pre-arranged trading plans.
When did an GMED insider last buy shares?
There has been no open market insider purchase of GMED in the last two years.
When did an GMED insider last sell shares?
James R Tobin (Director) sold 41,666 shares for $3.1M on Nov 10, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
